[1] |
Almenawer SA,Farrokhyar F,Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34829 patients[J]. Ann Surg, 2014, 259(3): 449-457.
|
[2] |
Lee L,Ker J,Ng HY, et al. Outcomes of chronic subdural hematoma drainage in nonagenarians and centenarians: a multicenter study[J]. J Neurosurg, 2015, 10(7): 1-6.
|
[3] |
Tanaka Y,Ohno K. Chronic subdural hematoma-an up-to-date concept[J]. J Med Dent Sci, 2013, 60(2): 55-61.
|
[4] |
D′Abbondanza JA,Loch Macdonald R. Experimental models of chronic subdural hematoma[J]. Neurol Res, 2014, 36(2): 176-188.
|
[5] |
Lega BC,Danish SF,Malhotra NR, et al. Choosing the best operation for chronic subdural hematoma: a decision analysis[J]. J Neurosurg, 2010, 113(3):615-621.
|
[6] |
肖智勇,胡志强,朱广通,等.软性神经内镜在慢性硬膜下血肿术中的应用[J].中华神经外科杂志, 2015, 31(9): 888-890.
|
[7] |
Lu J,Shen D,Hu F, et al. An improved electronic twist-drill craniostomy procedure with post-operative urokinase instillation in treating chronic subdural hematoma[J]. Clinl Neurol Neurosurg, 2015, 136(9): 61-65.
|
[8] |
Li T,Wang D,Tian Y, et al. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats[J]. J Neurol Sci, 2014, 341(1-2): 88-96.
|
[9] |
Wang D,Li T,Tian Y, et al. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers[J]. J Neurol Sci, 2014, 336(1-2): 237-242.
|
[10] |
Wood WG,Mller WE,Eckert GP. Statins and neuroprotection: basic pharmacology needed[J]. Mol neurobiol, 2014, 50(1): 214-220.
|
[11] |
Tu Q,Cao H,Zhong W, et al. Atorvastatin protects against cerebral ischemia reperfusion injury through anti-inflammatory and antioxidant effects[J]. Neural Rege Res, 2014, 9(3): 268-275.
|
[12] |
Martins WC,dos Santos VV,dos Santos AA, et al. Atorvastatin prevents cognitive deficits induced by intracerebroventricular amyloid-β1-40 administration in mice: involvement of glutamatergic and antioxidant systems[J]. Neurotox Res, 2015, 28(1): 32-42.
|
[13] |
Drapkin AJ. Chronic subdural hematoma: pathophysiological basis for treatment[J]. Br Neurosurg, 1991, 5(5): 467-473.
|